Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ILÚM Health Solutions developed ILÚM Insight, a real-time clinical decision support and surveillance platform for antimicrobial stewardship and infectious disease management in hospitals. Originally a Merck venture, ILÚM combined with Infectious Disease Connect in May 2020. Its technology, which improved identification and outcomes in sepsis and supported national antibiotic stewardship initiatives, continues to be offered as part of Infectious Disease Connect's services. Clinical pilots showed reduced hospital length-of-stay and improved guideline adherence in sepsis care.[3][6][7]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ILÚM Health Solutions.